339 related articles for article (PubMed ID: 6202716)
1. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
[TBL] [Abstract][Full Text] [Related]
2. Regulation of factor Xa in vitro in human and mouse plasma and in vivo in mouse. Role of the endothelium and plasma proteinase inhibitors.
Fuchs HE; Pizzo SV
J Clin Invest; 1983 Dec; 72(6):2041-9. PubMed ID: 6196377
[TBL] [Abstract][Full Text] [Related]
3. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
[TBL] [Abstract][Full Text] [Related]
4. In vivo catabolism of alpha 1-proteinase inhibitor-trypsin, antithrombin III-thrombin and alpha 2-macroglobulin-methylamine.
Fuchs HE; Shifman MA; Pizzo SV
Biochim Biophys Acta; 1982 May; 716(2):151-7. PubMed ID: 6178438
[TBL] [Abstract][Full Text] [Related]
5. Comparative interactions of factor IX and factor IXa with human platelets.
Ahmad SS; Rawala-Sheikh R; Walsh PN
J Biol Chem; 1989 Feb; 264(6):3244-51. PubMed ID: 2492533
[TBL] [Abstract][Full Text] [Related]
6. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
7. Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III.
Lollar P; Owen WG
J Clin Invest; 1980 Dec; 66(6):1222-30. PubMed ID: 6255009
[TBL] [Abstract][Full Text] [Related]
8. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
9. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
Rosenberg RD
Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
[TBL] [Abstract][Full Text] [Related]
10. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
11. The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.
Björk I; Jackson CM; Jörnvall H; Lavine KK; Nordling K; Salsgiver WJ
J Biol Chem; 1982 Mar; 257(5):2406-11. PubMed ID: 6977539
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte uptake of alpha 1-proteinase inhibitor-trypsin complexes in vitro: evidence for a shared uptake mechanism for proteinase complexes of alpha 1-proteinase inhibitor and antithrombin III.
Fuchs HE; Michalopoulos GK; Pizzo SV
J Cell Biochem; 1984; 25(4):231-43. PubMed ID: 6334690
[TBL] [Abstract][Full Text] [Related]
13. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
J Biol Chem; 1980 Nov; 255(21):10081-90. PubMed ID: 6448846
[TBL] [Abstract][Full Text] [Related]
14. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
[TBL] [Abstract][Full Text] [Related]
15. Binding of factors IX and IXa to cultured vascular endothelial cells.
Stern DM; Drillings M; Nossel HL; Hurlet-Jensen A; LaGamma KS; Owen J
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4119-23. PubMed ID: 6602986
[TBL] [Abstract][Full Text] [Related]
16. In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors.
Pratt CW; Church FC; Pizzo SV
Arch Biochem Biophys; 1988 Apr; 262(1):111-7. PubMed ID: 3258496
[TBL] [Abstract][Full Text] [Related]
17. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human factor Xa by various plasma protease inhibitors.
Ellis V; Scully M; MacGregor I; Kakkar V
Biochim Biophys Acta; 1982 Feb; 701(1):24-31. PubMed ID: 6173074
[TBL] [Abstract][Full Text] [Related]
19. Platelet procoagulant complex assembly in a tissue factor-initiated system.
Monroe DM; Roberts HR; Hoffman M
Br J Haematol; 1994 Oct; 88(2):364-71. PubMed ID: 7803283
[TBL] [Abstract][Full Text] [Related]
20. p-Amidino esters as irreversible inhibitors of factors IXa and Xa and thrombin.
Turner AD; Monroe DM; Roberts HR; Porter NA; Pizzo SV
Biochemistry; 1986 Aug; 25(17):4929-35. PubMed ID: 3490273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
